Portfolio company
Heartseed
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Heartseed develops cell-based regenerative therapies and transplantation devices for patients with severe heart failure and other cardiac diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Avery Therapeutics
Avery Therapeutics develops tissue-engineered heart grafts to treat patients with chronic heart failure.
CorInnova
The company develops a minimally invasive cardiac assist device to treat patients with acute heart failure without contacting the blood.
Cardior
This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.
CardioMech
CardioMech develops a transcatheter-based artificial chordae delivery system for hospitals to treat patients suffering from degenerative mitral regurgitation without open-heart surgery.
CSW Therapeutics
CSW Therapeutics develops a non-invasive soundwave therapy device for patients with refractory angina to regenerate heart tissue and restore cardiac function outside hospital settings.
Cardior Pharmaceuticals
This biopharmaceutical company develops RNA-based therapeutics to prevent and repair heart disease for patients with conditions such as heart failure and myocardial infarction.
Nuevocor
Nuevocor develops gene therapies for patients with genetic cardiomyopathies by addressing mechanical defects through its proprietary mechanobiology platform.
preCARDIA
This company develops catheter-based systems for heart failure specialists to treat patients suffering from acute decompensated heart failure and volume overload.